Archive - February 2019
First patient dosed in Gyroscope Therapeutics’ AMD study
Roche’s rival to Bayer’s Vitrakvi gets speedy FDA review
Report finds NICE’s routine appraisals need reform
Emergex to drive vaccine development with R&D facility and new hire
‘Inflexible’ NICE blocking access to rare disease drugs
Keytruda combination found to reduce risk of death in RCC
NovaBiotics given £1.8m to advance Novamycin
Opdivo shows promising results in Phase I/II trial
